James Kelly
Director of Finance/CFO bei NOVAVAX, INC.
Vermögen: 63 502 $ am 31.03.2024
Profil
Gegenwärtig ist James Patrick Kelly Chief Financial Officer, Treasurer und Executive VP von Novavax, Inc. Er ist außerdem Mitglied der Association of Bioscience Financial Officers. In seiner früheren Laufbahn war er Chief Financial Officer, Treasurer & Executive VP bei Vanda Pharmaceuticals, Inc. sowie Chief Financial Officer & Executive Vice President bei Supernus Pharmaceuticals, Inc. und Director-Planning & Operations bei Biogen, Inc. sowie Vice President & Controller bei Aetna, Inc. und MedImmune LLC. Herr Kelly erwarb einen MBA an der Cornell University und einen Bachelor-Abschluss an der University of Vermont.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
NOVAVAX, INC.
0,01% | 10.03.2024 | 13 285 ( 0,01% ) | 63 502 $ | 31.03.2024 |
Aktive Positionen von James Kelly
Unternehmen | Position | Beginn |
---|---|---|
NOVAVAX, INC. | Director of Finance/CFO | 16.08.2021 |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von James Kelly
Unternehmen | Position | Ende |
---|---|---|
SUPERNUS PHARMACEUTICALS, INC. | Director of Finance/CFO | 13.08.2021 |
VANDA PHARMACEUTICALS INC. | Director of Finance/CFO | 15.03.2020 |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Comptroller/Controller/Auditor | 01.12.2010 |
BIOGEN INC. | Corporate Officer/Principal | 01.11.2005 |
AETNA | Corporate Officer/Principal | 01.06.2000 |
Ausbildung von James Kelly
Cornell University | Masters Business Admin |
University of Vermont | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
BIOGEN INC. | Health Technology |
NOVAVAX, INC. | Health Technology |
VANDA PHARMACEUTICALS INC. | Health Technology |
SUPERNUS PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Aetna, Inc.
Aetna, Inc. Managed Health CareHealth Services Aetna, Inc. engages in the provision of traditional, voluntary, and consumer-directed health insurance products and related services. It offers benefits, products and services to individuals, employers, healthcare professionals, and producers. The company was founded by Eliphalet Adams Bulkeley in 1853 and is headquartered in Hartford, CT. | Health Services |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services The Association of Bioscience Financial Officers operates as a national networking group for biotechnology, med tech and bioscience financial officers. The company was founded in 1988 and is headquartered in Menlo Park, CA. | Commercial Services |